Events

RSA Inspiring Leaders Webinar w/ Jackie Hunter

In this webinar, participants will hear from four distinguished industry leaders with inspiring stories.

They will share insights on the experiences, people and decisions that shaped their successful careers, talking about what constitutes great leadership and how that contributes to innovative, breakthrough science.

Speakers
  • Jo Pisani, Non-Executive Director, The RSA Group
  • Dr. Niven R Narain, Co-founder, President & CEO, BERG
  • Prof. Jackie Hunter, Board Director BenevolentAI
  • Shiva Dustdar, Head of Division, Innovation Finance Advisory for the European Investment Bank
Who Should Attend?

Senior professionals who are:

  • Aspiring and existing leaders from any sector or background
  • Life science executives searching for leadership advice
  • Women in leadership looking for guidance and role models
  • C-suite professionals
What You Will Learn

In this webinar, participants will gain:

  • Advice from the experts on what good, effective, inclusive leadership means
  • How to achieve this leadership and the mindset needed to lead well
  • Insights on building resilience, facing adversity, embracing your differences and being confident
  • An understanding of why diversity is vital to success
  • Advice that leaders from any industry sector would gain incredible value from
Register here →


Jackie Hunter

Board Director of BenevolentAI

Jackie Hunter is a Board Director of BenevolentAI.  Jackie has over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She founded OI Pharma Partners in 2010 to support the life science sector in harnessing the power of open innovation and most recently was Chief Executive of the Biotechnology and Biological Sciences Research Council. She holds a personal chair from St George's Hospital Medical School, which was awarded in recognition of her contribution to bioscience research. In 2010 she was awarded a CBE in the Queen's Birthday Honours list for Services to the Pharmaceutical Industry.

More Posts

You Might Also Like

Blog
Transforming drug discovery with AI: how we’re building and nurturing the best talent for the job
At BenevolentAI, we are on a mission to bring life-changing medicines to patients, and we are looking for collaborative, mission-driven people to join our tech, drug discovery and business operations teams in London, Cambridge and New York.
Oct 17, 2021
News
BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies
BenevolentAI’s AI-Drug Discovery platform uncovered a novel target not previously linked to ulcerative colitis and advanced candidate to preclinical studies.
Oct 14, 2021
Blog
Measuring bias: moving towards more inclusive health research outcomes #stateofai
Having shared our open-source Diversity Analysis Tool last year, we were tasked to investigate and demonstrate the lack of diversity in biomedical data as part of the State of AI Report 2021.
Oct 12, 2021
Blog
Expert-augmented computational drug discovery for rare diseases
Combining scientific expertise, computational tools and our AI-enhanced biomedical knowledge graph to successfully uncover a new drug combination for treating a rare brain cancer in children.
Sep 28, 2021
News
BenevolentAI appoints Dr John Orloff to its Board of Directors
Biopharmaceutical veteran Dr John Orloff joins the BenevolentAI Board as a Non-Executive Director as it scales the development of its leading AI-derived drug pipeline.
Sep 9, 2021
Blog
AI in Drug Discovery
This blog seeks to demystify the application of artificial intelligence (AI) and machine learning (ML) in drug discovery by exploring some of the challenges, opportunities and progress that has been achieved in the field so far.
Jul 13, 2021